Olympus introduces new aspiration needle, EndoChoice short interest jumps 6.36% — 4 GI company key notes

Here are four recent news updates on key gastroenterology and endoscopy companies.

Olympus introduced the FDA-cleared EZ Shot 3 Plus single use aspiration needle.

EndoChoice stock declined 6.36 percent in short interest.

The European Commission approved the Swiss-based Novartis drug Afinitor for advanced gastrointestinal and lung neuroendocrine tumor treatment.

SpectraScience completed training for the first group of physicians using the WavSTAT4 Optical Biopsy SystemR in Barcelona, Spain.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast